CFC-Containing MDIs Are "Essential" Until Multiple Alternatives Available
This article was originally published in The Tan Sheet
Executive Summary
More than one CFC-free product alternative must be available before FDA phases out a CFC-containing metered dose inhaler that is available under multiple NDAs or in multiple strengths, the agency suggests in a proposed rule on ozone depleting substances (ODS) published in the Sept. 1 Federal Register.